• 1
    Freeman JA, Esrig D, Stein JP, Skinner DG. Management of the patient with bladder cancer. Urethral recurrence. Urol Clin North Am. 1994; 21: 645651.
  • 2
    Wolinska WH, Melamed MR, Schellhammer PF, Whitmore WF. Urethral cytology following cystectomy for bladder carcinoma. Am J Surg Pathol. 1977; 1: 225234.
  • 3
    Hickey DP, Soloway MS, Murphy WM. Selective urethrectomy following cystoprostatectomy for bladder cancer. J Urol. 1986; 136: 828830.
  • 4
    Lin DW, Herr HW, Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol. 2003; 169: 961963.
  • 5
    Nixon RG, Chang SS, Lafleur BJ, Smith JA Jr., Cookson MS. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol. 2002; 167: 502505.
  • 6
    Murphy WM. Urinary cytopathology. Chicago: ASCP Press, 2000: 1345.
  • 7
    Mendenhall W, Ott L, Larson RF. Statistics: a tool for the social sciences. 2nd edition. Belmont, CA: Duxbery Press,, 1974: 242248.
  • 8
    Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998; 22: 14351448.
  • 9
    Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumors. International classification of tumors, no. 19. Geneva: World Health Organization, 1973.